Glycerin

CHEMBL692 Phase 4 Zugelassen Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
92.1 g/mol
LogP
-1.8
Phase
4

A naturally derived compound with multiple medical uses including as an osmotic laxative for relieving constipation, an ingredient in ophthalmic solutions to reduce eye pressure in glaucoma, and a moisturizing agent in skin and throat preparations. It draws water into the bowel by osmosis to soften stools and stimulate bowel movements. It is also used in respiratory treatments and as a pharmaceutical excipient.

Molekularmasse

92,0900 g/mol

LogP

-1,80

TPSA

60,70 Ų

Lipinski-Regel der Fünf

Bestanden

Therapeutische Bereiche

Wirkmechanismus

Increases water content in the intestinal lumen through osmotic or stimulant mechanisms, promoting bowel motility and facilitating defecation.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanismus

Increases water content in the intestinal lumen through osmotic or stimulant mechanisms, promoting bowel motility and facilitating defecation.

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

OCC(O)CO

InChI

InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2

Molecular Formula

C3H8O3

HBD / HBA

3 / 3

Rotierbare Bindungen

2

Schwere Atome

6

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

A naturally derived compound with multiple medical uses including as an osmotic laxative for relieving constipation, an ingredient in ophthalmic solutions to reduce eye pressure in glaucoma, and a moisturizing agent in skin and throat preparations. It draws water into the bowel by osmosis to soften stools and stimulate bowel movements. It is also used in respiratory treatments and as a pharmaceutical excipient.

Increases water content in the intestinal lumen through osmotic or stimulant mechanisms, promoting bowel motility and facilitating defecation.

Yes, Glycerin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL692. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 753. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.